Single-center experience in the treatment of severe aortic stenosis with Xcor<sup>TM</sup> transcatheter aortic valve replacement system: 1-year follow-up results
The Xcor<sup>TM</sup> TAVR system demonstrated favorable early outcomes in severe aortic stenosis patients, significantly improving symptoms and hemodynamics while exhibiting excellent performance in preventing malignant arrhythmias and coronary obstruction.
Authors
- Hanbo Qiu (ORCID: https://orcid.org/0000-0001-5722-0141)
- Shengwen Wang
- Tong Tan (ORCID: https://orcid.org/0000-0002-3809-3551)
- Haipeng Liu (ORCID: https://orcid.org/0000-0002-4212-2503)
- Jimei Chen (ORCID: https://orcid.org/0000-0002-7866-7564)
- Haixia Xie (ORCID: https://orcid.org/0000-0002-5399-9458)
- Xiang Liu (ORCID: https://orcid.org/0009-0008-9958-745X)
- Haijiang Guo
Institutions
- Valve (United States) (US)
- Guangzhou Chemistry (China) (CN)
- Beijing Anzhen Hospital (CN)
- Guangdong Academy of Medical Sciences (CN)
- Guangdong Provincial People's Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Journal of Zhejiang University (Medical Sciences)
- Published
- 2025-03-01
- DOI
- https://doi.org/10.3724/zdxbyxb-2024-0487
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science and Technology Major Project